{"version":"1.0","type":"link","title":"FDA approves lurbinectedin in combination with atezolizumab for extensive-stage small cell lung cancer.","author_name":"Kepp O 외","author_url":"https://prs-insight.online/author/Kepp%20O","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/99769","thumbnail_width":1200,"thumbnail_height":630}